A major discovery in cancer study is occurring with the use of VHH fragments to re-engage dysfunctional p53. This crucial cancer suppressor protein is frequently inactivated in many forms of tumors, causing https://mediasocially.com/story6931285/mini-antibodies-revive-tumor-suppressor-p53-a-potential-pathway-for-malignant-therapy